Last quarter (Q4 2023), Genmab A/S's total revenue was kr―, a decrease of -100.00% from the same quarter last year. In Q4, Genmab A/S's net income was kr―. See Genmab A/S’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	kr 7.25B	kr 16.47B	kr 14.60B	kr 8.48B	kr 10.11B	kr 5.39B
Cost of Revenue	-	kr 226.00M	-	-	-	-
Gross Profit	-	kr 16.25B	kr 14.60B	-	-	-
Operating Expense	kr 4.07B	kr 10.93B	kr 8.24B	kr 5.46B	kr 3.80B	kr 2.59B
Operating Income	kr 3.18B	kr 5.32B	kr 6.36B	kr 3.02B	kr 6.31B	kr 2.80B
Net Non Operating Interest Income Expense	kr 1.33B	kr 1.21B	kr 303.00M	kr 184.00M	kr 174.00M	kr 113.00M
Other Income Expense	kr 1.25B	-	kr 659.00M	kr 781.00M	kr -583.00M	kr -46.00M
Pretax Income	kr 5.76B	kr 5.64B	kr 7.04B	kr 3.98B	kr 5.90B	kr 2.88B
Tax Provision	kr 1.29B	kr 1.28B	kr 1.51B	kr 975.00M	kr 1.15B	kr 719.00M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr 4.47B	kr 4.35B	kr 5.52B	kr 3.01B	kr 4.76B	kr 2.17B
Basic EPS	kr 68.42	kr 66.64	kr 84.47	kr 46.00	kr 73.00	kr 34.40
Diluted EPS	kr 67.83	kr 66.02	kr 83.65	kr 45.54	kr 72.21	kr 34.03
Basic Average Shares	kr 130.78M	kr 65.31M	kr 65.39M	kr 65.63M	kr 65.18M	kr 62.96M
Diluted Average Shares	kr 131.90M	kr 65.91M	kr 66.01M	kr 66.05M	kr 65.89M	kr 63.64M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 4.07B	kr 11.15B	kr 8.24B	kr 5.46B	kr 3.80B	kr 2.59B
Net Income From Continuing And Discontinued Operation	kr 4.47B	kr 4.35B	kr 5.52B	kr 3.01B	kr 4.76B	kr 2.17B
Normalized Income	kr 3.49B	-	-	kr 2.42B	kr 5.23B	kr 2.08B
Interest Expense	kr 206.00M	-	-	kr 13.00M	kr 10.00M	kr 7.00M
EBIT	kr 5.97B	-	-	kr 4.00B	kr 5.91B	kr 2.87B
EBITDA	kr 5.97B	-	-	kr 4.24B	kr 6.17B	kr 3.00B

Currency in DKK

Genmab A/S Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing